HIV Breakthrough as New Injection 89% More Effective Than PrEP
"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less information about how effective PrEP pills are among people who inject drugs, we know that PrEP pills reduce the risk of getting HIV by at least 74 percent when taken as prescribed," the CDC says.
Twice-Yearly Injection 96% Effective in Preventing HIV Infection
A twice-yearly injection of Sunlenca (lenacapavir) reduces the risk of HIV infection by 96%, which is significantly more effective than oral pre-exposure prophylaxis (PrEP) using pills like Truvada, researchers report in the New England Journal of Medicine.
HIV infections can be prevented – why some people act to protect themselves, and others don’t
People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
The Phase III Purpose 2 trial compared the safety and efficacy of twice-yearly subcutaneous lenacapavir for pre-exposure prophylaxis (PrEP) against once-daily oral Truvada.
Twice-Yearly Injection Reduces Risk of HIV Infection by 96%
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor's visits every three months and—most importantly—cons
'Huge relief' as new drug found to effectively prevent HIV infection
A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published research from the pivotal phase-three study "Purpose 2". The option to vaccinate against HIV only every six months is a genuine breakthrough,
TAG24 NEWS on MSN1d
Report confirms fewest new HIV cases since late 1980s – but experts warn decline is too slow
Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations ...
HIV prevention pills should be free, but insurers are still charging
Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment ...
The New Republic on MSN1dOpinion
Big Pharma Is the Only Reason Anyone Still Dies From HIV
While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...
Rising to the Challenge: what we need to do for a future without AIDS
Suniti Solomon's legacy lives on through YRGCARE's innovative approach to tackling HIV in India, inspiring hope and progress.
Kenya approves roll out of vaginal ring to protect women from HIV
Kenya’s ministry of health has approved the nationwide roll out of a vaginal ring to help women protect themselves from HIV.
Sierra Sun Times3h
Biden-⁠Harris Administration’s Efforts to End HIV/AIDS At Home and Abroad
Globally, under the Biden-Harris Administration, the President’s Emergency Plan for AIDS Relief (PEPFAR) released a five-year ...
Gilead's Twice-Yearly Lenacapavir Reduces HIV Infection Risk
According to a study published in the New England Journal of Medicine, twice-yearly injection of Lenacapavir offers a 96 percent ...
The Kenya Times on MSN3d
Bill Gates Opens Up on Finding Lifetime HIV Vaccine
U.S. philanthropist and entrepreneur Bill Gates has opened up about the search for a lifetime HIV vaccine, rather than one ...